Correlation Between Telkom Indonesia and INMED PHARMACEUTICALS

Can any of the company-specific risk be diversified away by investing in both Telkom Indonesia and INMED PHARMACEUTICALS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telkom Indonesia and INMED PHARMACEUTICALS into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Telkom Indonesia Tbk and INMED PHARMACEUTICALS INC, you can compare the effects of market volatilities on Telkom Indonesia and INMED PHARMACEUTICALS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telkom Indonesia with a short position of INMED PHARMACEUTICALS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telkom Indonesia and INMED PHARMACEUTICALS.

Diversification Opportunities for Telkom Indonesia and INMED PHARMACEUTICALS

-0.38

Correlation Coefficient

Telkom Indonesia  INMED PHARMACEUTICALS

Very good diversification

The 3 months correlation between Telkom and INMED is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Telkom Indonesia Tbk and INMED PHARMACEUTICALS INC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INMED PHARMACEUTICALS INC and Telkom Indonesia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telkom Indonesia Tbk are associated (or correlated) with INMED PHARMACEUTICALS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INMED PHARMACEUTICALS INC has no effect on the direction of Telkom Indonesia i.e., Telkom Indonesia and INMED PHARMACEUTICALS go up and down completely randomly.

Pair Corralation between Telkom Indonesia and INMED PHARMACEUTICALS

Assuming the 90 days trading horizon Telkom Indonesia Tbk is expected to generate 1.36 times more return on investment than INMED PHARMACEUTICALS. However, Telkom Indonesia is 1.36 times more volatile than INMED PHARMACEUTICALS INC. It trades about 0.1 of its potential returns per unit of risk. INMED PHARMACEUTICALS INC is currently generating about -0.04 per unit of risk. If you would invest  15.00  in Telkom Indonesia Tbk on September 26, 2024 and sell it today you would earn a total of  2.00  from holding Telkom Indonesia Tbk or generate 13.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.45%
Values	Daily Returns

Telkom Indonesia Tbk  vs.  INMED PHARMACEUTICALS INC

Telkom Indonesia Tbk

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Telkom Indonesia Tbk are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile forward indicators, Telkom Indonesia reported solid returns over the last few months and may actually be approaching a breakup point.

INMED PHARMACEUTICALS INC

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in INMED PHARMACEUTICALS INC are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain technical and fundamental indicators, INMED PHARMACEUTICALS reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Telkom Indonesia and INMED PHARMACEUTICALS

The main advantage of trading using opposite Telkom Indonesia and INMED PHARMACEUTICALS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telkom Indonesia position performs unexpectedly, INMED PHARMACEUTICALS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INMED PHARMACEUTICALS will offset losses from the drop in INMED PHARMACEUTICALS's long position.

The idea behind Telkom Indonesia Tbk and INMED PHARMACEUTICALS INC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.